Bibliographic Details
| Title: |
Terapia respiratoria inhalada y calentamiento global. |
| Alternate Title: |
Inhaled Respiratory Therapy and Global Warming. |
| Authors: |
Casanova-Martínez, Cristina1 cristina.casanova.martinez@sergas.es, Espino-Paisán, Esther1, Buján-de-Gonzalo, Laura1, Lema-Oreiro, Martina1, Álvarez-Sánchez, María José1 |
| Source: |
Farmacéuticos Comunitarios. abr2025, Vol. 17 Issue 2, p21-29. 9p. |
| Subjects: |
METERED-dose inhalers, RESPIRATORY therapy, ECOLOGICAL impact, GLOBAL warming, INHALERS |
| Abstract (English): |
INTRODUCTION: Hydrofluorocarbon (HFC) propellants used in current pressurized metered-dose inhalers (pMDIs) act as potent greenhouse gases, contributing to global warming. The objective of this study is to analyse the type and pattern of use of inhaler use in the Galician population, as well as to assess its impact on the carbon footprint. METHODOLOGY: This is an observational, descriptive, and retrospective study conducted in the autonomous community of Galicia in 2023. It included patients receiving pharmaceutical care from the Galician Health Service (SERGAS) who are being treated with bronchial inhalers for the management of their respiratory conditions. RESULTS: A total of 1.711.344 inhaler units were dispensed, equivalent to a carbon footprint of 15.247.142 kg CO2eq. pMDIs accounted for 43,17% (738.707) of the units dispensed in 2023, corresponding to almost 95,43% of the carbon footprint emitted by inhalers, with HFA-134a being the most used propellant (669.907 units). CONCLUSIONS: pMDIs contribute to global warming, generating nearly the entire carbon footprint emitted by inhalers used in respiratory therapy. SERGAS has implemented several strategies to reduce the environmental impact caused by pMDIs. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): |
INTRODUCCIÓN: los propelentes hidrofluorocarbonados (HFC) de los actuales inhaladores de cartucho presurizado (ICP) actúan como potentes gases de efecto invernadero, contribuyendo al calentamiento global. El objetivo de este trabajo es analizar el tipo y patrón de uso de inhaladores en la población gallega, así como analizar su impacto en la huella de carbono. METODOLOGÍA: estudio observacional, descriptivo y retrospectivo realizado en la comunidad autónoma de Galicia en el año 2023. Se incluyó a pacientes con prestación farmacéutica por el Servizo Galego de Saúde (SERGAS) que reciben tratamiento con inhaladores bronquiales para el manejo de su patología respiratoria. RESULTADOS: se dispensó un total de 1.711.344 envases de inhaladores, que equivale a una huella de carbono de 15.247.142 kg CO2eq. Los ICP representan el 43,17 % (738.707) de los envases de inhaladores dispensados en el año 2023, que se corresponde con casi el 95,43 % de la huella de carbono emitida por los inhaladores, siendo el HFA-134a el propelente mayoritario (669.907 envases). CONCLUSIONES: los ICP contribuyen al calentamiento global, originando casi el total de la huella de carbono emitida por los inhaladores utilizados en terapia respiratoria. El SERGAS ha puesto en marcha numerosas estrategias para reducir el impacto ambiental derivado de los ICP. [ABSTRACT FROM AUTHOR] |
|
Copyright of Farmacéuticos Comunitarios is the property of Sociedad Espanola de Farmacia Familiar y Comunitaria and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
MedicLatina |
